US Patent 9321765 Crystalline bromodomain inhibitors
Patent 9321765 was granted and assigned to AbbVie Inc. on April, 2016 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9321765 Crystalline bromodomain inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
